FDA
approval
· 2021-11-08
FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for AMNESTEEM (isotretinoin) by Mylan Pharmaceuticals Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMNESTEEM (ISOTRETINOIN)